Vivani Medical Inc (VANI)

$1.28 -0.02 (-1.54%)
Market Cap 112.11M
Revenue (ttm) 0.00
Net Income (ttm) -26.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 34,500
Avg Vol 532,886
Day's Range N/A - N/A
Shares Out 86.24M
Stochastic %K 17%
Beta 2.33
Analysts Strong Sell
Price Target $3.83

Company Profile

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 506 8462
Address:
1350 South Loop Road, Alameda, United States
bullseye86
bullseye86 Jul. 29 at 2:47 AM
$VANI took some at 1.30. Let’s see
0 · Reply
Kkai14
Kkai14 Jul. 28 at 10:12 AM
$VANI
0 · Reply
Vivani_Medical
Vivani_Medical Jul. 27 at 4:46 PM
$VANI CEO Adam Mendelsohn featured on Stocktwits' latest episode of Boardroom Exclusives: https://www.youtube.com/watch?v=KG7EqL-eTEc
0 · Reply
BC322032
BC322032 Jul. 23 at 1:41 PM
$VANI Gold for the win! ‘Big Short’ Billionaire Strikes $4.2 Billion Gold Deal https://www.benzinga.com/markets/commodities/26/07/60631213/big-short-billionaire-strikes-4-2-billion-gold-deal?utm_source=Flipboard&utm_campaign=partner_feed&utm_medium=referral
2 · Reply
BC322032
BC322032 Jul. 22 at 4:30 PM
$VANI
0 · Reply
Kkai14
Kkai14 Jul. 21 at 2:45 PM
$VANI
0 · Reply
JodieChristy
JodieChristy Jul. 17 at 3:26 PM
$VANI Added $50K this week and continuing to build a position in this range. Chairman Gregg Williams also purchased another $2M. The thesis: VANI is developing a small subdermal implant designed to deliver long-acting GLP-1 (semaglutide) for obesity and diabetes, potentially improving adherence vs. weekly injections. Key catalysts: Phase 1 data expected by end of 2026 Cash runway into mid-2027 Clinical-stage biotech remains high risk, but the obesity market opportunity is significant. Watching execution, data, and milestones.
0 · Reply
DonutHole
DonutHole Jul. 16 at 1:12 PM
$VANI Added to the list. https://www.realcreativeagency.com/best-penny-stocks-to-watch/
0 · Reply
focafoca99
focafoca99 Jul. 16 at 12:58 PM
$VANI projected its first dosing of SLIM-1 to occur in August 2026, per its Emerging Growth Conference presentation. https://www.rapidticker.com/news/vani-sec-filing-a4598f
0 · Reply
Mick10bagger
Mick10bagger Jul. 16 at 2:07 AM
$VANI What the hell. This is the best stock of all time. How in the world is not at least $5. I mean is everyone on crack. Is everyone here a crackhead?
1 · Reply
Latest News on VANI
Vivani Medical Transcript: Emerging Growth Conference

Jul 15, 2026, 4:10 PM EDT - 16 days ago

Vivani Medical Transcript: Emerging Growth Conference

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

Jul 14, 2026, 4:03 PM EDT - 17 days ago

Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Jul 11, 2026, 8:00 AM EDT - 20 days ago

A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139

2026-07-07T11:46:09.000Z - 24 days ago

Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139

NVO

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Jul 7, 2026, 7:35 AM EDT - 24 days ago

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Vivani Medical Slides: Corporate presentation

Jul 6, 2026, 7:00 AM EDT - 25 days ago

Vivani Medical Slides: Corporate presentation

Vivani Medical to merge Cortigent subsidiary with ClearOne

2026-07-02T12:20:21.000Z - 4 weeks ago

Vivani Medical to merge Cortigent subsidiary with ClearOne

CLRO

ClearOne enters into merger agreement with Cortigent

2026-07-02T12:05:14.000Z - 4 weeks ago

ClearOne enters into merger agreement with Cortigent

CLRO

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Jul 2, 2026, 8:00 AM EDT - 4 weeks ago

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

Jul 2, 2026, 8:00 AM EDT - 4 weeks ago

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

CLRO

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Jun 26, 2026, 7:30 AM EDT - 5 weeks ago

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Vivani receives approval from Bellberry to initiate SLIM-1 trial in Australia

2026-06-25T11:45:15.000Z - 5 weeks ago

Vivani receives approval from Bellberry to initiate SLIM-1 trial in Australia

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Jun 25, 2026, 7:30 AM EDT - 5 weeks ago

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Vivani Medical initiated with a Buy at Lake Street

2026-06-23T12:36:47.000Z - 5 weeks ago

Vivani Medical initiated with a Buy at Lake Street

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

Jun 22, 2026, 4:03 PM EDT - 5 weeks ago

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

Vivani Medical director buys $2.0M in common stock

2026-06-16T13:25:16.000Z - 6 weeks ago

Vivani Medical director buys $2.0M in common stock

Vivani Medical Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 11:05 AM EDT - 2 months ago

Vivani Medical Transcript: Jefferies Global Healthcare Conference 2026

Vivani Medical Slides: FY 2026

Jun 4, 2026, 11:05 AM EDT - 2 months ago

Vivani Medical Slides: FY 2026

Vivani Medical Slides: Corporate presentation

Jun 4, 2026, 7:00 AM EDT - 2 months ago

Vivani Medical Slides: Corporate presentation

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

May 13, 2026, 4:05 PM EDT - 2 months ago

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update

Vivani Medical Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 2 months ago

Vivani Medical Quarterly report: Q1 2026

Vivani Medical Earnings release: Q1 2026

May 13, 2026, 7:00 AM EDT - 2 months ago

Vivani Medical Earnings release: Q1 2026

Vivani Medical Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

Vivani Medical Proxy statement: Proxy filing

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

2026-03-31T15:51:53.000Z - 4 months ago

Vivani Medical price target lowered to $3.50 from $4 at H.C. Wainwright

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Mar 26, 2026, 4:16 PM EDT - 4 months ago

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Vivani Medical Earnings release: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 4 months ago

Vivani Medical Earnings release: Q4 2025

Vivani Medical Annual report: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 4 months ago

Vivani Medical Annual report: Q4 2025

Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026

2026-01-29T12:41:03.000Z - 6 months ago

Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Jan 29, 2026, 7:30 AM EST - 6 months ago

Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Jan 27, 2026, 4:05 PM EST - 6 months ago

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Jan 25, 2026, 11:36 PM EST - 6 months ago

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Vivani subsidiary to present poster on Orion Visual Cortical Prosthesis System

2026-01-22T12:18:05.000Z - 6 months ago

Vivani subsidiary to present poster on Orion Visual Cortical Prosthesis System

Vivani Medical Slides: Corporate presentation

Jan 9, 2026, 6:00 AM EST - 7 months ago

Vivani Medical Slides: Corporate presentation

Vivani Medical Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 9 months ago

Vivani Medical Quarterly report: Q3 2025

Vivani Medical Earnings release: Q3 2025

Nov 13, 2025, 8:00 AM EST - 9 months ago

Vivani Medical Earnings release: Q3 2025

Vivani Medical reports Q3 EPS (11c) vs (11c) last year

2025-11-13T12:50:35.000Z - 9 months ago

Vivani Medical reports Q3 EPS (11c) vs (11c) last year

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Nov 13, 2025, 7:45 AM EST - 9 months ago

Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results

Vivani Medical Transcript: 2025 ThinkEquity Conference

Oct 30, 2025, 1:30 PM EDT - 9 months ago

Vivani Medical Transcript: 2025 ThinkEquity Conference

Vivani Medical withdraws record date for spin-off of Cortigent

2025-10-03T12:35:29.000Z - 10 months ago

Vivani Medical withdraws record date for spin-off of Cortigent

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Oct 3, 2025, 8:30 AM EDT - 10 months ago

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off

Vivani Medical Transcript: Emerging Growth Conference 2025

Sep 25, 2025, 1:45 PM EDT - 11 months ago

Vivani Medical Transcript: Emerging Growth Conference 2025

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Sep 24, 2025, 9:15 AM EDT - 11 months ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025

Vivani Medical announces spin-off of Cortigent subsidiary

2025-09-17T12:40:31.000Z - 11 months ago

Vivani Medical announces spin-off of Cortigent subsidiary

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Sep 17, 2025, 8:30 AM EDT - 11 months ago

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders

Vivani Medical provides update on plans for NPM-139 semaglutide implant

2025-09-04T12:35:19.000Z - 11 months ago

Vivani Medical provides update on plans for NPM-139 semaglutide implant

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Sep 4, 2025, 8:30 AM EDT - 11 months ago

Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Aug 20, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:20 PM EDT - 1 year ago

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Vivani Medical Quarterly report: Q2 2025

Aug 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Quarterly report: Q2 2025

Vivani Medical Earnings release: Q2 2025

Aug 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Earnings release: Q2 2025

Vivani Medical reports results from LIBERATE-1 study of NPM-115

2025-08-05T12:21:25.000Z - 1 year ago

Vivani Medical reports results from LIBERATE-1 study of NPM-115

Vivani Medical appoints Baldor as Chief Financial Officer

2025-06-11T12:11:01.000Z - 1 year ago

Vivani Medical appoints Baldor as Chief Financial Officer

Vivani Medical files Form 10 registration statement for Cortigent spin-off

2025-05-29T12:40:35.000Z - 1 year ago

Vivani Medical files Form 10 registration statement for Cortigent spin-off

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

May 13, 2025, 4:30 PM EDT - 1 year ago

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

Vivani Medical Quarterly report: Q1 2025

May 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Quarterly report: Q1 2025

Vivani Medical Earnings release: Q1 2025

May 13, 2025, 12:00 AM EDT - 1 year ago

Vivani Medical Earnings release: Q1 2025

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

May 7, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

Vivani Medical Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

Vivani Medical Proxy statement: Proxy Filing

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Vivani Medical Proxy statement: Proxy Filing

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Vivani Medical Proxy statement: Proxy Filing

Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs

2025-04-15T12:40:34.000Z - 1 year ago

Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Apr 15, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

Vivani Medical Annual report: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Annual report: Q4 2024

Vivani Medical Earnings release: Q4 2024

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Earnings release: Q4 2024

Vivani Medical announces anticipated upcoming milestones

2025-03-31T11:42:16.000Z - 1 year ago

Vivani Medical announces anticipated upcoming milestones

Vivani Medical to focus on developing NPM-115, NPM-139, emerging pipeline

2025-03-31T11:41:55.000Z - 1 year ago

Vivani Medical to focus on developing NPM-115, NPM-139, emerging pipeline

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 31, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Vivani Medical Transcript: Emerging Growth Virtual Conference

Mar 27, 2025, 2:20 PM EDT - 1 year ago

Vivani Medical Transcript: Emerging Growth Virtual Conference

Vivani Medical Announces $8.25M Private Placement Equity Financing

Mar 27, 2025, 7:32 AM EDT - 1 year ago

Vivani Medical Announces $8.25M Private Placement Equity Financing

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Mar 24, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Emerging Growth Conference on March 27, 2025

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business

Vivani Medical Transcript: Emerging Growth Virtual Conference 78

Jan 16, 2025, 3:10 PM EST - 1 year ago

Vivani Medical Transcript: Emerging Growth Virtual Conference 78

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Dec 19, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Dec 4, 2024, 8:30 AM EST - 1 year ago

Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results

Vivani Medical Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Quarterly report: Q3 2024

Vivani Medical Slides: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Vivani Medical Slides: Q3 2024

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024

Vivani Medical Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Oct 17, 2024, 4:00 PM EDT - 1 year ago

Vivani Medical Transcript: Maxim Group’s 2024 Healthcare Virtual Summit

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Sep 26, 2024, 8:30 AM EDT - 2 years ago

Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Sep 23, 2024, 8:57 AM EDT - 2 years ago

Vivani Medical to Present at the Emerging Growth Conference on September 25, 2024

Vivani Medical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 11, 2024, 10:00 AM EDT - 2 years ago

Vivani Medical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Sep 4, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 28, 2024, 7:10 PM EDT - 2 years ago

Vivani Medical to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Vivani Medical Quarterly report: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Vivani Medical Quarterly report: Q2 2024

Vivani Medical Earnings release: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Vivani Medical Earnings release: Q2 2024

Vivani Medical Slides: Q2 2024

Aug 14, 2024, 4:00 PM EDT - 2 years ago

Vivani Medical Slides: Q2 2024

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Aug 13, 2024, 4:05 PM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Jul 11, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Jun 13, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

May 28, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

May 13, 2024, 4:45 PM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results

Vivani Medical Quarterly report: Q1 2024

May 13, 2024, 4:45 PM EDT - 2 years ago

Vivani Medical Quarterly report: Q1 2024

Vivani Medical Earnings release: Q1 2024

May 13, 2024, 4:45 PM EDT - 2 years ago

Vivani Medical Earnings release: Q1 2024

Vivani Medical Slides: Investor Presentation

May 13, 2024, 7:00 AM EDT - 2 years ago

Vivani Medical Slides: Investor Presentation

Vivani Medical to Present at TIDES Conference 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical to Present at TIDES Conference 2024

Vivani Medical Registration statement: Registration Filing

May 2, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Registration statement: Registration Filing

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Proxy statement: Proxy Filing

Vivani Medical Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Proxy statement: Proxy Filing

Vivani Medical Registration statement: Registration Filing

Apr 22, 2024, 8:00 AM EDT - 2 years ago

Vivani Medical Registration statement: Registration Filing

Vivani Medical Earnings release: Q4 2023

Mar 26, 2024, 9:30 AM EDT - 2 years ago

Vivani Medical Earnings release: Q4 2023

Vivani Medical Annual report: Q4 2023

Mar 26, 2024, 9:30 AM EDT - 2 years ago

Vivani Medical Annual report: Q4 2023

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 26, 2024, 8:30 AM EDT - 2 years ago

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Mar 6, 2024, 8:00 AM EST - 2 years ago

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Mar 1, 2024, 7:49 AM EST - 2 years ago

Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants

Vivani Medical (VANI) stock price surged: is it a good buy?

Feb 29, 2024, 7:25 AM EST - 2 years ago

Vivani Medical (VANI) stock price surged: is it a good buy?

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Feb 28, 2024, 8:30 AM EST - 2 years ago

Vivani Medical Announces Positive NPM-115 Preclinical Weight Loss Data Comparable to Ozempic®/Wegovy® and Discloses NPM-139 as Semaglutide as Strategy Shifts to Prioritize Obesity Portfolio

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Nov 14, 2023, 6:00 AM EST - 2 years ago

Vivani Medical Provides Business Update and Reports Third Quarter Financial Results

Vivani Medical Quarterly report: Q3 2023

Nov 14, 2023, 6:00 AM EST - 2 years ago

Vivani Medical Quarterly report: Q3 2023

Vivani Medical Earnings release: Q3 2023

Nov 14, 2023, 6:00 AM EST - 2 years ago

Vivani Medical Earnings release: Q3 2023

Vivani Medical to Present at BIO Investor Forum

Oct 16, 2023, 6:00 AM EDT - 3 years ago

Vivani Medical to Present at BIO Investor Forum

bullseye86
bullseye86 Jul. 29 at 2:47 AM
$VANI took some at 1.30. Let’s see
0 · Reply
Kkai14
Kkai14 Jul. 28 at 10:12 AM
$VANI
0 · Reply
Vivani_Medical
Vivani_Medical Jul. 27 at 4:46 PM
$VANI CEO Adam Mendelsohn featured on Stocktwits' latest episode of Boardroom Exclusives: https://www.youtube.com/watch?v=KG7EqL-eTEc
0 · Reply
BC322032
BC322032 Jul. 23 at 1:41 PM
$VANI Gold for the win! ‘Big Short’ Billionaire Strikes $4.2 Billion Gold Deal https://www.benzinga.com/markets/commodities/26/07/60631213/big-short-billionaire-strikes-4-2-billion-gold-deal?utm_source=Flipboard&utm_campaign=partner_feed&utm_medium=referral
2 · Reply
BC322032
BC322032 Jul. 22 at 4:30 PM
$VANI
0 · Reply
Kkai14
Kkai14 Jul. 21 at 2:45 PM
$VANI
0 · Reply
JodieChristy
JodieChristy Jul. 17 at 3:26 PM
$VANI Added $50K this week and continuing to build a position in this range. Chairman Gregg Williams also purchased another $2M. The thesis: VANI is developing a small subdermal implant designed to deliver long-acting GLP-1 (semaglutide) for obesity and diabetes, potentially improving adherence vs. weekly injections. Key catalysts: Phase 1 data expected by end of 2026 Cash runway into mid-2027 Clinical-stage biotech remains high risk, but the obesity market opportunity is significant. Watching execution, data, and milestones.
0 · Reply
DonutHole
DonutHole Jul. 16 at 1:12 PM
$VANI Added to the list. https://www.realcreativeagency.com/best-penny-stocks-to-watch/
0 · Reply
focafoca99
focafoca99 Jul. 16 at 12:58 PM
$VANI projected its first dosing of SLIM-1 to occur in August 2026, per its Emerging Growth Conference presentation. https://www.rapidticker.com/news/vani-sec-filing-a4598f
0 · Reply
Mick10bagger
Mick10bagger Jul. 16 at 2:07 AM
$VANI What the hell. This is the best stock of all time. How in the world is not at least $5. I mean is everyone on crack. Is everyone here a crackhead?
1 · Reply
wolfcyd3
wolfcyd3 Jul. 15 at 11:30 PM
$VANI https://www.investing.com/news/transcripts/vivani-medical-at-emerging-growth-conference-implant-push-gains-traction-93CH-4794499
0 · Reply
wolfcyd3
wolfcyd3 Jul. 15 at 1:47 AM
$VANI 793,650 @1.26 july, 15th
1 · Reply
Vivani_Medical
Vivani_Medical Jul. 14 at 8:33 PM
$VANI Hear a company update from $VANI CEO Adam Mendelsohn at the Emerging Growth Conference this week: 7/15 at 4:10 p.m. EDT. Register here: https://goto.webcasts.com/starthere.jsp?ei=1764180&tp_key=8f1191cdb2&sti=vanihttps://goto.webcasts.com/starthere.jsp?ei=1764180&tp_key=8f1191cdb2&sti=vani
0 · Reply
Vivani_Medical
Vivani_Medical Jul. 14 at 8:32 PM
$VANI
0 · Reply
focafoca99
focafoca99 Jul. 14 at 8:10 PM
$VANI expects to present at the Emerging Growth Conference on July 15, 2026. https://www.rapidticker.com/news/vani-vivani-medical-to-present-at-aeaeb5
0 · Reply
djotc
djotc Jul. 13 at 2:58 AM
$VANI will we see 2 bucks this week?
0 · Reply
FibonacciFortress
FibonacciFortress Jul. 12 at 2:48 PM
$NVO inks a long-acting GLP-1 implant tech deal with $VANI. Interesting setup for both names: $NVO keeps extending its obesity/diabetes toolkit $VANI gets validation on its implant platform Not a hype print, but this kind of pairing can keep sentiment constructive around GLP-1 delivery tech.
0 · Reply
wolfcyd3
wolfcyd3 Jul. 11 at 1:54 PM
$VANI GLP-1 implant from Vivani Medical aims to help patients stay on treatment https://www.cnbc.com/2026/07/11/glp-1-implant-from-vivani-medical-aims-to-help-patients-stay-on-treatment.html
0 · Reply
BC322032
BC322032 Jul. 10 at 4:01 PM
$VANI Well todays selloff was unneccesary!
1 · Reply
Kkai14
Kkai14 Jul. 10 at 10:59 AM
$VANI Slowly creeping back up...
1 · Reply
Kkai14
Kkai14 Jul. 9 at 7:27 PM
$TOP and $VANI 💵💵
0 · Reply
FNMAMAN
FNMAMAN Jul. 9 at 4:04 PM
$VANI insider buying. Very
0 · Reply